Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Canadian Considerations and Sourcing Canadian researchers and those exploring peptide therapy face specific considerations around sourcing, legality, and practical access
Heres what makes it appetite-neutral: Mechanism: Activates lipolysis via beta-3 adrenergic receptors in fat tissue Appetite Impact: No effect on hunger, satiety, or food intake patterns Cortisol: Does not elevate cortisol levels (unlike full growth hormone) Administration: Subcutaneous injection, typically daily Typical Dosing: 250-500 mcg daily before breakfast Metabolic Effects: Increases fat oxidation without affecting insulin or glucose Best For: Individuals seeking fat loss while maintaining normal eating patterns Key Difference: Works directly on fat tissue, not through appetite regulation The following guide provides complete details on AOD-9604s appetite-neutral fat loss mechanism, from cellular pathways to practical implementation protocols
Offers the highest bioavailability and fastest results
Other symptoms to follow are headache, face swelling, shortness of breath, a tendency to vomit etc
Watch for cloudiness, visible particles or precipitate, a color shift (most peptides are colorless GHK-Cu is the exception and reads blue, which is normal), or foam that will not settle
US$ 22.25
US$ 27.07
US$ 26.62
US$ 21.09